CA2386876A1 - Combination chemotherapy - Google Patents

Combination chemotherapy Download PDF

Info

Publication number
CA2386876A1
CA2386876A1 CA002386876A CA2386876A CA2386876A1 CA 2386876 A1 CA2386876 A1 CA 2386876A1 CA 002386876 A CA002386876 A CA 002386876A CA 2386876 A CA2386876 A CA 2386876A CA 2386876 A1 CA2386876 A1 CA 2386876A1
Authority
CA
Canada
Prior art keywords
dose
paclitaxel
carboplatin
combination
acetyldinaline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002386876A
Other languages
English (en)
French (fr)
Inventor
Wayne Daniel Klohs
Ronald Lynn Merriman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2386876A1 publication Critical patent/CA2386876A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002386876A 1999-11-10 2000-11-03 Combination chemotherapy Abandoned CA2386876A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16488999P 1999-11-10 1999-11-10
US60/164,889 1999-11-10
US22256100P 2000-08-03 2000-08-03
US60/222,561 2000-08-03
PCT/US2000/030377 WO2001034131A2 (en) 1999-11-10 2000-11-03 Combination chemotherapy

Publications (1)

Publication Number Publication Date
CA2386876A1 true CA2386876A1 (en) 2001-05-17

Family

ID=26860956

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002386876A Abandoned CA2386876A1 (en) 1999-11-10 2000-11-03 Combination chemotherapy

Country Status (17)

Country Link
EP (1) EP1229916A2 (es)
JP (1) JP2003513912A (es)
KR (1) KR20020060226A (es)
CN (1) CN1387438A (es)
AR (1) AR026400A1 (es)
AU (1) AU1583201A (es)
CA (1) CA2386876A1 (es)
GT (1) GT200000194A (es)
HU (1) HUP0203153A3 (es)
IL (1) IL149363A0 (es)
NZ (1) NZ518668A (es)
PA (1) PA8506201A1 (es)
PE (1) PE20011028A1 (es)
PL (1) PL355170A1 (es)
SV (1) SV2001000212A (es)
UY (1) UY26431A1 (es)
WO (1) WO2001034131A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
PE20050206A1 (es) * 2003-05-26 2005-03-26 Schering Ag Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
US9115090B2 (en) 2003-12-02 2015-08-25 The Ohio State University Research Foundation Zn2+-chelating motif-tethered short-chain fatty acids as a novel class of histone deacetylase inhibitors
US7951780B2 (en) * 2004-02-25 2011-05-31 Astellas Pharma Inc. Antitumor agent
EP2322217A3 (en) * 2004-07-16 2011-09-28 Pfizer Products Inc. Combination treatment for non-hematologic malignancies using an anti-IGF-1R antibody
EP2415382B1 (en) 2010-08-06 2012-08-29 Electrolux Home Products Corporation N.V. Table top dishwasher
EP3461488A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dbait molecule and a hdac inhibitor for treating cancer
EP3461480A1 (en) 2017-09-27 2019-04-03 Onxeo Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
WO2023041805A1 (en) 2021-09-20 2023-03-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for improving the efficacy of hdac inhibitor therapy and predicting the response to treatment with hdac inhibitor
WO2023194441A1 (en) 2022-04-05 2023-10-12 Istituto Nazionale Tumori Irccs - Fondazione G. Pascale Combination of hdac inhibitors and statins for use in the treatment of pancreatic cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases

Also Published As

Publication number Publication date
NZ518668A (en) 2004-04-30
EP1229916A2 (en) 2002-08-14
PL355170A1 (en) 2004-04-05
PA8506201A1 (es) 2002-12-11
HUP0203153A2 (hu) 2003-01-28
KR20020060226A (ko) 2002-07-16
WO2001034131A3 (en) 2002-05-10
HUP0203153A3 (en) 2005-01-28
CN1387438A (zh) 2002-12-25
PE20011028A1 (es) 2001-10-12
WO2001034131A2 (en) 2001-05-17
AR026400A1 (es) 2003-02-12
SV2001000212A (es) 2001-10-25
AU1583201A (en) 2001-06-06
UY26431A1 (es) 2000-12-29
IL149363A0 (en) 2002-11-10
JP2003513912A (ja) 2003-04-15
GT200000194A (es) 2002-05-03

Similar Documents

Publication Publication Date Title
AU762079B2 (en) Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
EP2786753B1 (en) Combination therapy with an antitumor antibiotic
JP2011140521A (ja) タキサンにより惹起される神経毒性を予防又は軽減するための薬剤
CA2386876A1 (en) Combination chemotherapy
JP2005525409A5 (es)
US5767110A (en) Combination chemotherapy
EP1273296B1 (en) Combination of acetyldinaline and docetaxel
Dobson et al. Cancer chemotherapy
MXPA04006822A (es) Combinaciones que comprenden epotilonas y anti-metabolitos.
US6939893B2 (en) Method of reducing toxicity of anticancer agents
US20030134893A1 (en) Combination chemotherapy
MXPA01003074A (es) Quimioterapia para tratar el cancer con acetildinalina en combinacion con gemcitabina, capecitabina o cisplatina

Legal Events

Date Code Title Description
FZDE Discontinued